Relapse of NPM1-Mutated AML with Extramedullary Manifestation 17 Years after Allogeneic Hematopoietic Stem Cell Transplantation

The majority of patients with acute myeloid leukemia (AML) with the NPM1 mutation achieve remission with intensive chemotherapy. However, many patients subsequently relapse, which occurs frequently within the first 2–3 years after therapy, while late relapse after more than 10 years is rare and can...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Jan Braune, Kathrin Rieger, Olga Blau, Ulrich Keller, Lars Bullinger, Jan Krönke
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Wiley 2022-01-01
Edice:	Case Reports in Hematology
On-line přístup:	http://dx.doi.org/10.1155/2022/3317936
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!